By U.S. FDA Recalls — July 24, 2026 – Taoyuan City, Taiwan – Sunny Pharmtech, Inc is voluntarily recalling three lots of Cyclophosphamide for Injection, USP, 1g/vial and 2g/vial, to the User Level due to the presence of particulate matter identified as steel. To date, no adverse events or injuries associated with this pa
Read the original at U.S. FDA Recalls ↗
Auto-published by the finit.news Events monitor from U.S. FDA Recalls; summarized by AI and may contain errors — verify against the primary source. July 26, 2026.